Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.

Rahnemai-Azar AA, Cloyd JM, Weber SM, Dillhoff M, Schmidt C, Winslow ER, Pawlik TM.

J Clin Transl Hepatol. 2018 Mar 28;6(1):97-104. doi: 10.14218/JCTH.2017.00060. Epub 2017 Nov 30. Review.

2.

Portal Vein Embolization: State-of-the-Art Technique and Options to Improve Liver Hypertrophy.

Huang SY, Aloia TA.

Visc Med. 2017 Dec;33(6):419-425. doi: 10.1159/000480034. Epub 2017 Nov 24. Review.

PMID:
29344515
3.

Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients.

Luz JHM, Luz PM, Bilhim T, Martin HS, Gouveia HR, Coimbra É, Gomes FV, Souza RR, Faria IM, de Miranda TN.

Cancer Imaging. 2017 Sep 20;17(1):25. doi: 10.1186/s40644-017-0127-3.

4.

Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Kim BJ, Day RW, Davis CH, Narula N, Kroll MH, Tzeng CWD, Aloia TA.

J Thromb Haemost. 2017 Nov;15(11):2158-2164. doi: 10.1111/jth.13814. Epub 2017 Sep 27.

PMID:
28846822
5.

A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery.

Aloia TA, Kim BJ, Segraves-Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM, Popat KU, Rahlfs TF, Lee JE, Wang XS, Morris JS, Gottumukkala VNR, Vauthey JN.

Ann Surg. 2017 Sep;266(3):545-554. doi: 10.1097/SLA.0000000000002386.

PMID:
28746153
6.
7.

An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence.

Cai YL, Song PP, Tang W, Cheng NS.

Medicine (Baltimore). 2016 Jun;95(24):e3941. doi: 10.1097/MD.0000000000003941. Review.

8.

Portal Vein Embolization as an Oncosurgical Strategy Prior to Major Hepatic Resection: Anatomic, Surgical, and Technical Considerations.

Orcutt ST, Kobayashi K, Sultenfuss M, Hailey BS, Sparks A, Satpathy B, Anaya DA.

Front Surg. 2016 Mar 11;3:14. doi: 10.3389/fsurg.2016.00014. eCollection 2016. Review.

9.

Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes.

Loffroy R, Favelier S, Chevallier O, Estivalet L, Genson PY, Pottecher P, Gehin S, Krausé D, Cercueil JP.

Quant Imaging Med Surg. 2015 Oct;5(5):730-9. doi: 10.3978/j.issn.2223-4292.2015.10.04. Review. Erratum in: Quant Imaging Med Surg. 2016 Oct;6(5):619-620.

10.

Strategies to increase the resectability of hepatocellular carcinoma.

She WH, Chok KSh.

World J Hepatol. 2015 Aug 28;7(18):2147-54. doi: 10.4254/wjh.v7.i18.2147. Review.

11.

Definition of Readmission in 3,041 Patients Undergoing Hepatectomy.

Brudvik KW, Mise Y, Conrad C, Zimmitti G, Aloia TA, Vauthey JN.

J Am Coll Surg. 2015 Jul;221(1):38-46. doi: 10.1016/j.jamcollsurg.2015.01.063. Epub 2015 Feb 28.

12.

Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy.

Mise Y, Aloia TA, Conrad C, Huang SY, Wallace MJ, Vauthey JN.

J Gastrointest Surg. 2015 Jan;19(1):133-41; discussion 141. doi: 10.1007/s11605-014-2617-y. Epub 2014 Aug 5.

13.

Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.

Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN.

J Surg Oncol. 2014 Aug;110(2):107-14. doi: 10.1002/jso.23626. Epub 2014 May 21.

14.

Portal vein embolization and ligation for extended hepatectomy.

Vyas S, Markar S, Partelli S, Fotheringham T, Low D, Imber C, Malago M, Kocher HM.

Indian J Surg Oncol. 2014 Mar;5(1):30-42. doi: 10.1007/s13193-013-0279-y. Epub 2014 Jan 6. Review.

15.

Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival.

Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN.

Br J Surg. 2013 Dec;100(13):1777-83. doi: 10.1002/bjs.9317.

16.

Portal vein embolization for hepatocellular carcinoma.

Shindoh J, D Tzeng CW, Vauthey JN.

Liver Cancer. 2012 Nov;1(3-4):159-67. doi: 10.1159/000343829. Review.

17.

Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.

Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA.

J Am Coll Surg. 2013 Jul;217(1):126-33; discussion 133-4. doi: 10.1016/j.jamcollsurg.2013.03.004. Epub 2013 Apr 28.

18.

Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.

Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN.

Ann Surg Oncol. 2013 Aug;20(8):2493-500. doi: 10.1245/s10434-012-2864-7. Epub 2013 Feb 3.

19.

Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.

Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN.

J Am Coll Surg. 2013 Feb;216(2):201-9. doi: 10.1016/j.jamcollsurg.2012.10.018. Epub 2012 Dec 7.

20.

Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections.

Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA, Vauthey JN.

J Gastrointest Surg. 2013 Jan;17(1):57-64; discussion p.64-5. doi: 10.1007/s11605-012-2000-9. Epub 2012 Sep 7.

Supplemental Content

Support Center